Pyxis Oncology, Inc. (PYXS) stock
PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.44+0.03 (+2.13%)
Close on Nov 17, 2026Market cap $120.11MP/E –Yield –
Pyxis Oncology price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Pyxis Oncology's price to book ratio was 9.1× on Nov 11, 2026, against 4.7× a year earlier. Over the last 5 years it ranged from 0.2× to 18.0×, with a median of 0.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 9.1× | +8.1 |
| 2025 | Dec 31, 2025 | 1.0× | +0.4 |
| 2024 | Dec 31, 2024 | 0.6× | +0.0 |
| 2023 | Dec 29, 2023 | 0.6× | +0.3 |
| 2022 | Dec 30, 2022 | 0.2× | – |
See a number that looks wrong?